Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Risk Assessment generated by a regulatory process
(RA)
last updated: 31 May 2017
Application code: GMR07001 To import for release genetically modified Canarypox virus vaccines (Proteqflu and Proteqflu Te) to protect horses against equine influenza
EN
-
Competent National Authority:Environmental Protection Authority ()Private Bag 63002Wellington,
6140, New ZealandPhone: +64 (0)4 474 5591,Fax: +64 (0)4 914 0433,Email: neworganisms@epa.govt.nz,
-
Proteqflu - equine influenza vaccine| Merial | Production of medical or pharmaceutical compounds (human or animal) (Vaccines), Use as vaccine
| Record type | Field | Record(s) | |
|---|---|---|---|
| Country's Decision or any other Communication | Risk assessment | 2 | |
